CRANN’s scientific challenge is to develop new nanomaterials (e.g. Graphene) with improved mechanical, magnetic, optical or electrical properties and their subsequent application in electronic, medical devices, sensors or new drug delivery systems. CRANN maintains a strategic balance between fundamental and industry-guided research. Our industry partners include several well-known multinationals, including Intel and Hewlett-Packard, as well as a number of small to medium sized indigenous companies, such as Aerogen and Proxy Biomedical.
Explore Crann's Research Areas >
CRANN has had an exceptional 2012, publishing in excess of 180 papers in international peer reviewed journals. Importantly a significant number of these papers are in high impact journals including Nature Methods, ACS Nano and Nature Protocols.
CRANN Principal Investigators are drawn from across Trinity College Dublin and University College Cork from multiple disciplines.
CRANN has active research relations with more than 150 research institutions in numerous countries around the world and is central to all the primary nanoscience initiatives in Ireland.
The 8th framework programme will run from 2014 to 2020. It has been given the name Horizon2020.